{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T21:11:11Z","timestamp":1723065071044},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Supportive Cancer Therapy"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.3816\/sct.2005.n.010","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T01:12:34Z","timestamp":1221095554000},"page":"176-180","source":"Crossref","is-referenced-by-count":16,"title":["The Role of Methadone in the Treatment of Moderate to Severe Cancer Pain"],"prefix":"10.3816","volume":"2","author":[{"given":"Lauren","family":"Shaiova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/SCT.2005.n.010_bib1","first-page":"130","article-title":"Essential drugs in palliative care","volume":"6","author":"Dickerson","year":"1999","journal-title":"Eur J Palliative Care"},{"key":"10.3816\/SCT.2005.n.010_bib2","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1200\/JCO.2001.19.11.2898","article-title":"Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study","volume":"111","author":"Mercadante","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.3816\/SCT.2005.n.010_bib3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0304-3959(92)90065-J","article-title":"Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat","volume":"48","author":"Gong","year":"1992","journal-title":"Pain"},{"key":"10.3816\/SCT.2005.n.010_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0304-3959(96)03286-1","article-title":"An update on the clinical use of methadone for cancer pain","volume":"70","author":"Ripamonti","year":"1997","journal-title":"Pain"},{"key":"10.3816\/SCT.2005.n.010_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00023210-199708010-00003","article-title":"CNS adverse effects of opioids in cancer patients: guidelines for drug treatment","volume":"8","author":"Ripamonti","year":"1997","journal-title":"CNS Drugs"},{"key":"10.3816\/SCT.2005.n.010_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2165\/00003088-198611020-00001","article-title":"High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment","volume":"11","author":"Sawe","year":"1986","journal-title":"Clin Pharmacokinet"},{"key":"10.3816\/SCT.2005.n.010_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0885-3924(86)80042-2","article-title":"A randomized study on oral administration of morphine and methadone in the treatment of cancer pain","volume":"1","author":"Ventafridda","year":"1986","journal-title":"J Pain Symptom Manage"},{"key":"10.3816\/SCT.2005.n.010_bib8","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/1097-0142(19951001)76:7<1283::AID-CNCR2820760728>3.0.CO;2-0","article-title":"Opioid pharmacotherapy in the management of cancer pain: A survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration","volume":"76","author":"Cherney","year":"1995","journal-title":"Cancer"},{"key":"10.3816\/SCT.2005.n.010_bib9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/BF00542117","article-title":"Pharmacokinetics of methadone in methadone maintenance treatment: characterization of therapeutic failures","volume":"25","author":"Nilsson","year":"1983","journal-title":"Eur J Clin Pharmacol"},{"key":"10.3816\/SCT.2005.n.010_bib10","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/cpt1972136923","article-title":"Disposition of methadone in man after a single oral dose","volume":"13","author":"Inturrisi","year":"1972","journal-title":"Clin Pharmacol Ther"},{"key":"10.3816\/SCT.2005.n.010_bib11","series-title":"Cancer Pain Relief","author":"World Health Organization","year":"1986"},{"key":"10.3816\/SCT.2005.n.010_bib12","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/(SICI)1097-0142(19990415)85:8<1849::AID-CNCR27>3.0.CO;2-6","article-title":"Treatment and outcome of cancer pain in advanced cancer patients followed at home","volume":"85","author":"Mercadante","year":"1999","journal-title":"Cancer"},{"key":"10.3816\/SCT.2005.n.010_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0304-3959(96)03313-1","article-title":"Intravenous methadone for cancer pain unrelieved by morphine and hydromorphone: clinical observation","volume":"70","author":"Manfredi","year":"1997","journal-title":"Pain"},{"key":"10.3816\/SCT.2005.n.010_bib14","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0304-3959(97)00118-8","article-title":"Intravenous high dose methadone administered by patient controlled analgesia and continuous infusion for the treatment of cancer pain refractory to high-dose morphine","volume":"73","author":"Fitzgibbon","year":"1997","journal-title":"Pain"},{"key":"10.3816\/SCT.2005.n.010_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0304-3940(95)11364-3","article-title":"Ketobemidone, methadone and pethidine are noncompetitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortexand spinal cord","volume":"187","author":"Ebert","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.3816\/SCT.2005.n.010_bib16","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1167::AID-CNCR23>3.0.CO;2-3","article-title":"Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study","volume":"82","author":"Lawlor","year":"1998","journal-title":"Cancer"},{"key":"10.3816\/SCT.2005.n.010_bib17","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0006-2952(98)00088-4","article-title":"Opioid analgesics as noncompetitive N-methyl-D-aspartate (NMDA) antagonist","volume":"56","author":"Ebert","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"10.3816\/SCT.2005.n.010_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/J354v16n01_04","article-title":"Clinical use of methadone","volume":"16","author":"Layson-Wolf","year":"2002","journal-title":"J Pain Palliat Pharmacother"},{"key":"10.3816\/SCT.2005.n.010_bib19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0885-3924(00)00252-9","article-title":"Methadone analgesia in cancer pain patients in chronic methadone maintenance therapy","volume":"21","author":"Manfredi","year":"2001","journal-title":"J Pain Symptom Manage"},{"key":"10.3816\/SCT.2005.n.010_bib20","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1749-6632.1976.tb27945.x","article-title":"Drug interaction with methadone","volume":"281","author":"Kreek","year":"1976","journal-title":"Ann N Y Acad Sci"},{"key":"10.3816\/SCT.2005.n.010_bib21","first-page":"2773","article-title":"Plasma and urine levels of methadone. Comparison following four medication forms used in chronic maintenaince treatment","volume":"73","author":"Kreek","year":"1973","journal-title":"N Y State J Med"},{"key":"10.3816\/SCT.2005.n.010_bib22","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1360-0443.1997.tb02866.x","article-title":"Patterns of symptoms complaints in methadone maintenance patients","volume":"92","author":"Dyer","year":"1997","journal-title":"Addiction"},{"key":"10.3816\/SCT.2005.n.010_bib23","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1200\/JCO.1999.17.10.3307","article-title":"Rapid switching form morphine to methadone in cancer patients with poor response to morphine","volume":"17","author":"Mercadente","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.3816\/SCT.2005.n.010_bib24","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0749-0690(18)30213-1","article-title":"Opioid analgesics in the elderly","volume":"12","author":"Forman","year":"1996","journal-title":"Clin Geriatr Med"},{"issue":"2","key":"10.3816\/SCT.2005.n.010_bib25","first-page":"CD003971","article-title":"Methadone for cancer pain","author":"Nicholson","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.3816\/SCT.2005.n.010_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1090-3801(97)90064-1","article-title":"Methadone in cancer pain","volume":"1","author":"Mercadente","year":"1997","journal-title":"Eur J Pain"}],"container-title":["Supportive Cancer Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543291213600569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543291213600569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T23:06:01Z","timestamp":1557788761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1543291213600569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S1543291213600569"],"URL":"https:\/\/doi.org\/10.3816\/sct.2005.n.010","relation":{},"ISSN":["1543-2912"],"issn-type":[{"value":"1543-2912","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}